Search Results - "Jaisser, Frederic"
-
1
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
Published in Nature reviews. Nephrology (01-01-2022)“…Chronic kidney disease (CKD) is the leading complication in type 2 diabetes (T2D) and current therapies that limit CKD progression and the development of…”
Get full text
Journal Article -
2
Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases
Published in Annual review of physiology (10-02-2022)“…Mineralocorticoid receptor (MR) activation in the heart and vessels leads to pathological effects, such as excessive extracellular matrix accumulation,…”
Get full text
Journal Article -
3
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
Published in The Journal of clinical investigation (01-07-2012)“…Central serous chorioretinopathy (CSCR) is a vision-threatening eye disease with no validated treatment and unknown pathogeny. In CSCR, dilation and leakage of…”
Get full text
Journal Article -
4
Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1
Published in Journal of the American Society of Nephrology (01-04-2017)“…AKI is a frequent complication in hospitalized patients. Unfortunately, there is no effective pharmacologic approach for treating or preventing AKI. In…”
Get full text
Journal Article -
5
Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction
Published in Hypertension (Dallas, Tex. 1979) (01-04-2016)“…Mineralocorticoid receptor (MR) antagonists slow down the progression of heart failure after myocardial infarction (MI), but the cell-specific role of MR in…”
Get full text
Journal Article -
6
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
Published in Handbook of experimental pharmacology (01-01-2017)“…Characterization of mice with cell-specific deletion or overexpression of the mineralocorticoid receptor (MR) shed a new light on its role in health and…”
Get more information
Journal Article -
7
Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade
Published in Journal of investigative dermatology (01-01-2020)“…Skin ulcers resulting from impaired wound healing are a serious complication of diabetes. Unresolved inflammation, associated with the dysregulation of both…”
Get full text
Journal Article -
8
Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics
Published in Expert opinion on investigational drugs (02-11-2021)“…Mineralocorticoid receptor (MR) antagonists (MRAs) provide cardiorenal protection. However steroidal MRAs might induce hyperkalemia and sex hormone-related…”
Get more information
Journal Article -
9
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase
Published in Hypertension (Dallas, Tex. 1979) (01-07-2015)“…Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascular diseases. Pharmacological antagonism of the…”
Get full text
Journal Article -
10
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Published in Nature communications (21-01-2019)“…Choroidal neovascularization (CNV) is a major cause of visual impairment in patients suffering from wet age-related macular degeneration (AMD), particularly…”
Get full text
Journal Article -
11
CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation: Mechanistic Insights and Clinical Implications
Published in Hypertension (Dallas, Tex. 1979) (01-03-2019)“…Myocardial fibrosis is a main contributor to the development of heart failure (HF). CT-1 (cardiotrophin-1) and Gal-3 (galectin-3) are increased in HF and…”
Get full text
Journal Article -
12
Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion
Published in PloS one (23-02-2018)“…Excess mineralocorticoid receptor (MR) activation promotes target organ dysfunction, vascular injury and fibrosis. MR antagonists like eplerenone are used for…”
Get full text
Journal Article -
13
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Published in Hypertension (Dallas, Tex. 1979) (01-10-2015)“…Hypertensive cardiac remodeling is accompanied by molecular inflammation and fibrosis, 2 mechanisms that finally affect cardiac function. At cardiac level,…”
Get full text
Journal Article -
14
Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
Published in Kidney international supplements (01-04-2022)“…Chronic kidney disease is a major global health challenge, and mineralocorticoid receptor (MR) signaling is thought to play a role in disease progression. The…”
Get full text
Journal Article -
15
Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction
Published in Hypertension (Dallas, Tex. 1979) (01-09-2018)“…Enhanced activation of the endothelial mineralocorticoid receptor contributes to the development of arterial stiffness, which is an independent predictor of…”
Get full text
Journal Article -
16
Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot's acute neuroarthropathy
Published in PloS one (21-05-2020)“…Aggressive antidiabetic therapy and rapid glycemic control are associated with diabetic neuropathy. Here we investigated if this is also the case for Charcot…”
Get full text
Journal Article -
17
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Published in Kidney international (01-05-2011)“…Slowing the progression of chronic kidney diseases (CKDs) requires new and effective treatment approaches. Aldosterone classically acts on the distal nephron:…”
Get full text
Journal Article -
18
Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure
Published in Hypertension (Dallas, Tex. 1979) (01-11-2015)“…Arteriolar vasoreactivity tightly regulates tissue-specific blood flow and contributes to systemic blood pressure (BP) but becomes dysfunctional in the setting…”
Get full text
Journal Article -
19
Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice
Published in Metabolism, clinical and experimental (01-10-2019)“…Mineralocorticoid receptor activation of the epithelial sodium channel in endothelial cells (ECs) (EnNaC) is accompanied by aldosterone induced endothelial…”
Get full text
Journal Article -
20
Epithelial Sodium Channel Stiffens the Vascular Endothelium In Vitro and in Liddle Mice
Published in Hypertension (Dallas, Tex. 1979) (01-05-2013)“…Liddle syndrome, an inherited form of hypertension, is caused by gain-of-function mutations in the epithelial Na channel (ENaC), the principal mediator of Na…”
Get full text
Journal Article